Stage IVB Rectal Cancer Not Yet Recruiting Phase 1 / 2 Trials for Encorafenib (DB11718)

IndicationStatusPhase
DBCOND0028589 (Stage IVB Rectal Cancer)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04044430Encorafenib, Binimetinib, and Nivolumab in Treating Patients With Microsatellite Stable BRAFV600E Metastatic Colorectal CancerTreatment